Showing 951-960 of 1059 results for "".
- Labcorp Launches New Amyloid-Tau-Neurodegeneration Biomarker Blood Testhttps://practicalneurology.com/news/labcorp-launches-new-amyloid-tau-neurodegeneration-biomarker-blood-test/2470308/Labcorp has announced that its ATN Profile (Laboratory Corporation of America Holdings, Burlington, NC) test for identifying and assessing biological changes in blood biomarkers associated with Alzheimer disease (AD) has launched and is available in the United States. Physicians can use the tests
- Favorable Skin Tolerability and Adhesion Results Found in Study of Adlarity Transdermal Patcheshttps://practicalneurology.com/news/favorable-skin-tolerability-and-adhesion-results-found-in-study-of-adlarity-transdermal-patches/2470298/Results of a study published online in Alzheimer Disease & Associated Disorders revealed favorable outcomes in terms of skin tolerability and adhesion for Adlarity (donepezil transdermal system; Corium, Boston, MA) compared with placebo. The Food and Drug Administration (FDA) approve
- Stroke Risk Increases Significantly After Head Injury, 30-Year Study Findshttps://practicalneurology.com/news/stroke-risk-increases-significantly-after-head-injury-30-year-study-finds/2470292/People who have experienced traumatic brain injury (TBI), regardless of severity, are at significantly greater risk of ischemic stroke, according to a study presented at the 148th Annual Meeting of the American Neurological Association. The study also found that the risk of ischemic stroke increa
- Probiotics May Have Beneficial Effects in Patients with Parkinson Diseasehttps://practicalneurology.com/news/probiotics-may-have-beneficial-effects-in-patients-with-parkinson-disease/2470277/Probiotic use may be associated with improved Parkinson disease (PD) symptoms, according to studies presented at the 2023 International Congress of Parkinson’s Disease and Movement Disorders. Results from one study suggest that prolonged probiotic use may have potential as a therapy for pat
- Study Finds Evidence of Link Between Absence Seizures and Myelin Plasticityhttps://practicalneurology.com/news/study-finds-evidence-of-link-between-absence-seizures-and-myelin-plasticity/2470079/Results from a novel study presented at the American Epilepsy Society Annual Meeting revealed an association between seizures and myelin plasticity, opening exciting possibilities for future research. Researchers documented an increase in both the total number of myelinated fibers as well as thic
- MRI Reveals Enlarged Perivascular Spaces in Individuals With Migrainehttps://practicalneurology.com/news/mri-reveals-enlarged-perivascular-spaces-in-individuals-with-migraine/2470074/A new study presented at the annual meeting of the Radiological Society of North America (RSNA) was the first to report evidence of enlarged perivascular spaces in study participants with migraine. Researchers also documented an association between the number of enlarged perivascular spaces found
- Genomic Transposable Elements Could Modify the Progression of Parkinson Diseasehttps://practicalneurology.com/news/genomic-transposable-elements-could-modify-the-progression-of-parkinson-disease/2470064/Researchers from a study evaluated how transposable elements were associated with Parkinson disease (PD) subtypes and impact disease trajectory. The study analyzed the variation of transposable elements and the impact on different trajectories of PD. Patient data from the PD Progression Markers I
- High-Frequency Spinal Cord Stimulation Included in Endocrinology Guideline for Painful Diabetic Neuropathy Treatmenthttps://practicalneurology.com/news/high-frequency-spinal-cord-stimulation-included-in-endocrinology-guideline-for-painful-diabetic-neuropathy-treatment/2470037/High-frequency (10 kHz) spinal cord stimulation (HF-SCS) is now included in the Diabetes Clinical Practice Guideline for painful diabetic neuropathy (PDN) treatment by The Association of Clinical Endocrinology (AACE). Inclusion of HF-SCS was based on the results from the SENZA-PDN trial (
- FDA Approves Expanded Indication for Use of Stiripentol for Dravet Syndrome in Children Age 6 Months or Morehttps://practicalneurology.com/news/fda-approves-expanded-indication-for-use-of-stiripentol-for-dravet-syndrome-in-children-age-6-months-or-more/2470029/The Food and Drug Administration (FDA) has approved stiripentol (Diacomit; Biocodex, San Mateo, CA) for the treatment of seizures associated with Dravet Syndrome in patients 6 months of age and older, weighing 15 lbs or more and taking clobazam. In 2 clinical studies, the drug
- Pediatric Migraine Frequency Increased During COVID-19 Pandemichttps://practicalneurology.com/news/pediatric-migraine-frequency-increased-during-covid-19-pandemic/2469996/Data published in the Journal of Child Neurology suggest that elevation of stress associated with disruptions to daily life, social distancing practices, and COVID-19 anxiety greatly affected children with headache disorders. A new study of children with headache showed that headache fre